5-(4-(3-(5-methyl-2-phenyl-4-oxazolyl)propionyl)benzyl)-2,4-thiazolidinedione,
CP 86325,
CP-86,325,
CP-86325,
darglitazone,
darglitazone sodium,
Darglitazone,
141200-24-0,
5-[[4-[3-(5-methyl-2-phenyl-1,3-oxazol-4-yl)propanoyl]phenyl]methyl]-1,3-thiazolidine-2,4-dione,
Darglitazone [INN],
[3H]Darglitazone,
AC1Q6GK7,
DSSTox_CID_31433,
DSSTox_RID_97319,
DSSTox_GSID_57644,
SCHEMBL37497,
CHEMBL55624,
AC1L1U33,
DTXSID3057644,
BDBM33297,
QQKNSPHAFATFNQ-UHFFFAOYSA-N,
Tox21_113876,
NCGC00253763-01,
2,4-Thiazolidinedione, 5-((4-(3-(5-methyl-2-phenyl-4-oxazolyl)-1-oxopropyl)phenyl)methyl)-, (+-)-,
CAS-141200-24-0,
88071-EP2270011A1,
88071-EP2272825A2,
88071-EP2272841A1,
88071-EP2298776A1,
88071-EP2301936A1,
88071-EP2305648A1,
5-[4-(3-(5-Methyl-2-phenyl-4-oxazolyl)propionyl)benzyl]thiazolidine-2,4-dione,
5-[4-[3-(5-Methyl-2-phenyl-4-oxazolyl)propanoyl]benzyl]thiazolidine-2,4-dione,
UNII-AVP9C03Z3K,
Darglitazone < Rec INN,
DARGLITAZONE SODIUM,
D0N1EF,
AVP9C03Z3K,
CID60870,
C23-H20-N2-O4-S,
CP-86325,
CP 86325,
CP-86,325,
C089948,
5-(4-(3-(5-methyl-2-phenyl-4-oxazolyl)propionyl)benzyl)-2,4-thiazolidinedione,
Rac-5-[4-[3-(5-Methyl-2-phenyloxazol-4-yl)propionyl]benzyl]thiazolidine-2,4-dione,
125549-25-9,